乐观
$38.45
情景价格
$31.220
-0.069 (-0.22%)收盘时
Option Care Health, Inc. is an independent provider of home and alternate site infusion services. Its infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of over 87 full-service pharmacies and 109 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women's health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient's condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.
Option Care Health Inc is currently priced at $31.22, which is close to the acquisition price of $32.05 set by McKesson and CD&R. The RSI is at 83.77, indicating it is overbought, which suggests caution for new buyers. The stock has seen a significant 35.33% increase over the last 20 days, but the recent downgrades from analysts suggest that the stock may not have much upside left in the short term. The main risk is the potential for regulatory hurdles or shareholder disapproval regarding the acquisition, which could impact the stock's price negatively.
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Investor Rights Law Firm Investigates Multiple Companies

Investor Rights Law Firm Investigates Multiple Companies for Potential Violations

Investor Rights Law Firm Investigates Multiple Companies

Investigation into Option Care Health Acquisition Fairness

Option Care Health Shares Surge on Acquisition News
Option Care Health, Inc. is an independent provider of home and alternate site infusion services. Its infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of over 87 full-service pharmacies and 109 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women's health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient's condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).
Option Care Health Inc is currently priced at $31.22, which is close to the acquisition price of $32.05 set by McKesson and CD&R. The RSI is at 83.77, indicating it is overbought, which suggests caution for new buyers. The stock has seen a significant 35.33% increase over the last 20 days, but the recent downgrades from analysts suggest that the stock may not have much upside left in the short term. The main risk is the potential for regulatory hurdles or shareholder disapproval regarding the acquisition, which could impact the stock's price negatively.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。